Real-World Assessment of Efficacy and Safety Parameters for Dapagliflozin in Management of Type 2 Diabetes Mellitus: REWARD Study
Introduction: While ample evidence on improved glycemic control, weight reduction, and lowered blood pressure (BP) with sodium-glucose cotransporter type 2 inhibitors (SGLT2is) exists, real-world data on the potential benefit of SGLT2i on the diabetic population in the Middle East are lacking. The a...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Knowledge E
2022-01-01
|
| Seri Bilgileri: | Dubai Diabetes and Endocrinology Journal |
| Konular: | |
| Online Erişim: | https://www.karger.com/Article/FullText/519871 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|